Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)
Close on Nov 18, 2026Market cap $71.09MP/E –Yield –
Zhengye Biotechnology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zhengye Biotechnology's total debt was CN¥65.80M at Dec 31, 2025. For fiscal 2025 it was CN¥65.80M, down 23.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥65.80M | -23.9% |
| FY2024 | Dec 31, 2024 | CN¥86.43M | -3.8% |
| FY2023 | Dec 31, 2023 | CN¥89.85M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | CN¥65.80M | – |
| Q2 FY2025 | Jun 30, 2025 | CN¥81.06M | – |
| Q4 FY2024 | Dec 31, 2024 | CN¥86.43M | – |
| Q4 FY2023 | Dec 31, 2023 | CN¥89.85M | – |
See a number that looks wrong?